These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23362554)

  • 1. [MRI and PET in Alzheimer's disease].
    Matsunari I
    No Shinkei Geka; 2012 Dec; 40(12):1051-63. PubMed ID: 23362554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Application of 4-D medical imaging in radiation therapy of tumors].
    Li FX; Li JB; Zhang YJ
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):721-5. PubMed ID: 22335901
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospective interest of molecular neuroimaging in Alzheimer's disease.
    Guedj E
    Rev Neurol (Paris); 2013 Jan; 169(1):9-13. PubMed ID: 22682055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal image data fusion for Alzheimer's Disease diagnosis by sparse representation.
    Ortiz A; Fajardo D; Górriz JM; Ramírez J; Martínez-Murcia FJ
    Stud Health Technol Inform; 2014; 207():11-8. PubMed ID: 25488206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
    Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
    Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.
    Mosconi L; Tsui WH; De Santi S; Li J; Rusinek H; Convit A; Li Y; Boppana M; de Leon MJ
    Neurology; 2005 Jun; 64(11):1860-7. PubMed ID: 15955934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modern methods of functional tomographic brain imaging for brain function reseaching in norm and pathology].
    Kireev MV; Zakhs DV; Korotkov AD; Medvedev SV
    Ross Fiziol Zh Im I M Sechenova; 2013 Jan; 99(1):53-62. PubMed ID: 23659056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurovisualization in the differential diagnosis of dementia].
    Vlasenko AG; Illarioshkin SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6):86-90. PubMed ID: 22983255
    [No Abstract]   [Full Text] [Related]  

  • 10. Imaging biomarkers in Alzheimer's disease: added value in the clinical setting.
    Morbelli S; Bauckneht M; Scheltens P
    Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):360-371. PubMed ID: 28750495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Workflow in Simultaneous PET/MRI.
    Barbosa Fde G; von Schulthess G; Veit-Haibach P
    Semin Nucl Med; 2015 Jul; 45(4):332-44. PubMed ID: 26050660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body simultaneous positron emission tomography (PET)-MR: optimization and adaptation of MRI sequences.
    Fowler KJ; McConathy J; Narra VR
    J Magn Reson Imaging; 2014 Feb; 39(2):259-68. PubMed ID: 24436150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of multiple myeloma: usefulness of MRI and PET/CT.
    Koppula B; Kaptuch J; Hanrahan CJ
    Semin Ultrasound CT MR; 2013 Dec; 34(6):566-77. PubMed ID: 24332208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging through the course of Alzheimer's disease.
    Smith CD
    J Alzheimers Dis; 2010; 19(1):273-90. PubMed ID: 20061644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical guide for implementing hybrid PET/MR clinical service: lessons learned from our experience.
    Parikh N; Friedman KP; Shah SN; Chandarana H
    Abdom Imaging; 2015 Aug; 40(6):1366-73. PubMed ID: 25985966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do We Need Yet Another Hybrid Imaging Device?
    Divgi C
    Acad Radiol; 2016 Feb; 23(2):131. PubMed ID: 26719162
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of segmentation-based attenuation correction methods for PET/MRI: evaluation of bone and liver standardized uptake value with oncologic PET/CT data.
    Kim JH; Lee JS; Song IC; Lee DS
    J Nucl Med; 2012 Dec; 53(12):1878-82. PubMed ID: 23081993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid PET/MR imaging: physics and technical considerations.
    Shah SN; Huang SS
    Abdom Imaging; 2015 Aug; 40(6):1358-65. PubMed ID: 25985965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From PET/CT to PET/MRI: advances in instrumentation and clinical applications.
    Hu Z; Yang W; Liu H; Wang K; Bao C; Song T; Wang J; Tian J
    Mol Pharm; 2014 Nov; 11(11):3798-809. PubMed ID: 25058336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.